Integrate.ai, a SaaS company, is playing a key role in the Canadian Platform for Genomics and Precision Health (CP4GPH), which seeks to improve healthcare outcomes for Canadians by allowing AI-powered discoveries across networks of data. By leveraging integrate.ai’s technology, the platform enables privacy-preserving federated analytics and AI, providing a safe way for researchers to activate data silos and derive insights across distributed datasets without sharing, moving, or providing direct access to data between organizations. This project will potentially revolutionize the precision health industry, enabling job creation, high-value research and ultimately driving innovation and advancing insights across critical use cases, including precision medicine, drug discovery, clinical trials, and more.
Integrate.ai, a SaaS (Software as a Service) company, has announced its central role in the Canadian Platform for Genomics and Precision Health (CP4GPH), which aims to deliver better outcomes for Canadians by making it easier to derive AI-powered discoveries across networks of data in neuroscience, oncology, rare disease, infectious disease, health care, agriculture, and beyond. The platform, which is funded in part by Digital, will enable privacy-preserving federated analytics and AI through integrate.ai’s technology, allowing researchers to safely activate data silos and derive insights across distributed datasets without sharing, moving, or providing direct access to data between organizations.
Data is crucial in precision health, but traditional approaches like centralized data sharing are inefficient, insecure, and impractical for sensitive health data. Furthermore, ever-evolving regulations have restricted researchers’ access to quality patient data, further limiting advances in this space. The CP4GPH, combining the latest standards for data interoperability with AI-powered technologies for federated learning, is creating a new way for organizations to safely collaborate to unlock value from the world’s exponentially growing volumes of genomic and health data.
Integrate.ai’s software enables AI and analytic work across sensitive data silos without needing to move the data, providing maximum protection and unblocking critical innovation in genomics and precision health. Since the location and control of the data remain unchanged, privacy and security can be maintained, and data can be utilized according to patient consent. This project will put Canada at the forefront of precision health, driving innovation, enabling job creation, and cultivating high-value research and discovery.
The CP4GPH will cultivate an open innovation ecosystem that additional stakeholders can plug into and will ultimately commercialize globally-leading solutions to manage, share, analyze, and translate insights from genomics and health data. Organizations can safely accelerate access to secure, interoperable data and advance insights across critical use cases, including precision medicine, drug discovery, clinical trials, collaborative research, corporate data silos, risk underwriting, fraud detection, and more.
The CP4GPH is a ground-breaking software platform that aims to revolutionize the precision health industry. By enabling privacy-preserving federated analytics and AI, researchers can safely activate data silos and derive insights across distributed datasets without sharing, moving, or providing direct access to data between organizations. The project will cultivate an open innovation ecosystem and commercialize globally-leading solutions to manage, share, analyze, and translate insights from genomics and health data.
Image provided by cottonbro studio
